Literature DB >> 24954674

The expanding universe of disorders of the basal ganglia.

Jose A Obeso1, Maria C Rodriguez-Oroz2, Maria Stamelou3, Kailash P Bhatia4, David J Burn5.   

Abstract

The basal ganglia were originally thought to be associated purely with motor control. However, dysfunction and pathology of different regions and circuits are now known to give rise to many clinical manifestations beyond the association of basal ganglia dysfunction with movement disorders. Moreover, disorders that were thought to be caused by dysfunction of the basal ganglia only, such as Parkinson's disease and Huntington's disease, have diverse abnormalities distributed not only in the brain but also in the peripheral and autonomic nervous systems; this knowledge poses new questions and challenges. We discuss advances and the unanswered questions, and ways in which progress might be made.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24954674     DOI: 10.1016/S0140-6736(13)62418-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

1.  The changing tree in Parkinson's disease.

Authors:  Paolo Calabresi; Massimiliano Di Filippo
Journal:  Nat Neurosci       Date:  2015-09       Impact factor: 24.884

2.  Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Authors:  Gaetano Barbagallo; Maria Eugenia Caligiuri; Gennarina Arabia; Andrea Cherubini; Angela Lupo; Rita Nisticò; Maria Salsone; Fabiana Novellino; Maurizio Morelli; Giuseppe Lucio Cascini; Domenico Galea; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

3.  Structural connectivity differences in essential tremor with and without resting tremor.

Authors:  Maria Eugenia Caligiuri; Gennarina Arabia; Gaetano Barbagallo; Angela Lupo; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Andrea Quattrone; Maria Salsone; Basilio Vescio; Andrea Cherubini; Aldo Quattrone
Journal:  J Neurol       Date:  2017-07-20       Impact factor: 4.849

4.  Altered coupling of spontaneous brain activities and brain temperature in patients with adolescent-onset, first-episode, drug-naïve schizophrenia.

Authors:  Zhiyong Zhao; Guojun Xu; Bin Sun; Xuzhou Li; Zhe Shen; Shangda Li; Yi Xu; Manli Huang; Dongrong Xu
Journal:  Neuroradiology       Date:  2019-03-06       Impact factor: 2.804

5.  The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

Authors:  Bekir B Artukoglu; Michael H Bloch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

6.  Cross-Cutting Advancements Usher in a New Era for Motor Research in Psychosis.

Authors:  Vijay A Mittal
Journal:  Schizophr Bull       Date:  2016-08-18       Impact factor: 9.306

Review 7.  Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Authors:  Daniel Martinez-Ramirez; Michael S Okun; Michael S Jaffee
Journal:  Neurodegener Dis Manag       Date:  2016-07-13

8.  Cognitive motor impairments and brain structure in schizophrenia spectrum disorder patients with a history of catatonia.

Authors:  Derek J Dean; Neil Woodward; Sebastian Walther; Maureen McHugo; Kristan Armstrong; Stephan Heckers
Journal:  Schizophr Res       Date:  2020-05-15       Impact factor: 4.939

Review 9.  What Can Different Motor Circuits Tell Us About Psychosis? An RDoC Perspective.

Authors:  Vijay A Mittal; Jessica A Bernard; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

10.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.